AbhishekMangaonkarMD
Hematology • Rochester, MNHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Assistant Professor and Senior Associate Consultant, Mayo Clinic
Dr. Mangaonkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Summary
- I am a hematology/oncology fellow at the Mayo Clinic.
Education & Training
Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2016 - 2019
Medical College of GeorgiaResidency, Internal Medicine, 2013 - 2016
Grant Medical CollegeClass of 2012
Certifications & Licensure
MN State Medical License 2016 - 2025
MA State Medical License 2020 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
American Journal of Hematology. 2024-12-13 - 1 citationsHigh-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.Zhuoer Xie, Jenna Fernandez, Terra Lasho, Christy Finke, Michelle Amundson
Blood. 2024-12-05 - Single cell multiomics reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response.Wazim Mohammed Ismail, Jenna Fernandez, Moritz Binder, Terra L Lasho, Minsuk Kim
Blood Advances. 2024-12-04
Journal Articles
- Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring SideroblastsAbhishek A Mangaonkar, Kebede H Begna, Leukemia Research
Authored Content
- Prognostic Impact of ASXL1 Mutations in Patients with Myelodysplastic Syndromes and Multilineage Dysplasia with or Without Ring SideroblastsJuly 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
